Mallinckrodt Plc
(NYSE Amex Equities : MNK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly & Co. 0.02%371.141.1%$1218.86m
JNJJohnson & Johnson 0.38%178.680.7%$1164.51m
MRKMerck & Co., Inc. -0.20%109.910.7%$1039.23m
PFEPfizer Inc. 1.90%51.080.9%$1007.75m
ABBVAbbVie, Inc. 0.23%161.551.9%$870.23m
BMYBristol-Myers Squibb Co. 0.89%81.001.1%$767.41m
AZNAstraZeneca Plc 0.71%68.461.0%$363.41m
HZNPHorizon Therapeutics Plc 0.88%101.185.4%$308.82m
IDXXIDEXX Laboratories, Inc. 3.11%439.123.9%$238.81m
CTLTCatalent, Inc. 4.43%52.351.9%$232.61m
GSKGSK Plc 1.24%35.020.3%$196.44m
NVSNovartis AG 0.34%89.870.2%$189.62m
NVONovo Nordisk A/S 1.30%126.220.1%$174.98m
ALNYAlnylam Pharmaceuticals, Inc. 0.26%221.168.0%$162.55m
RGENRepligen Corp. 5.04%187.866.7%$140.68m

Company Profile

Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes innovative specialty pharmaceutical brands. The Specialty Generics segment relates to niche specialty generic drugs and active pharmaceutical ingredients. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.